AC
REGN icon

Alexandria Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Alexandria Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$6.96M Buy
11,505
+471
+4% +$292K 0.64% 55
2021
Q2 		$6.16M Buy
11,034
+5,514
+100% +$2.79M 0.57% 65
2021
Q1 		$2.61M Buy
5,520
+797
+17% +$388K 0.26% 104
2020
Q4 		$2.28M Sell
4,723
-3,369
-42% -$1.82M 0.24% 108
2020
Q3 		$4.53M Buy
8,092
+2,168
+37% +$1.31M 0.54% 65
2020
Q2 		$3.69M Buy
5,924
+3,874
+189% +$2.2M 0.48% 70
2020
Q1 		$1M Buy
2,050
+291
+17% +$120K 0.16% 123
2019
Q4 		$660K Buy
+1,759
New +$592K 0.09% 153
2017
Q4 		– Sell
-6
Closed -$3K – 450
2017
Q3 		$3K Sell
6
-6
-50% -$2.85K ﹤0.01% 486
2017
Q2 		$6K Buy
12
+2
+20% +$875 ﹤0.01% 471
2017
Q1 		$4K Sell
10
-409
-98% -$152K ﹤0.01% 506
2016
Q4 		$154K Sell
419
-3,350
-89% -$1.27M 0.04% 150
2016
Q3 		$1.51M Sell
3,769
-1,097
-23% -$440K 0.28% 70
2016
Q2 		$1.7M Sell
4,866
-3
-0.1% -$1.16K 0.3% 75
2016
Q1 		$1.75M Buy
4,869
+2,973
+157% +$1.23M 0.32% 70
2015
Q4 		$1.03M Hold
1,896
– – 0.26% 78
2015
Q3 		$882K Sell
1,896
-1
-0.1% -$537 0.21% 83
2015
Q2 		$1.03M Buy
1,897
+1,875
+8,523% +$915K 0.23% 78
2015
Q1 		$10K Sell
22
-1
-4% -$424 ﹤0.01% 399
2014
Q4 		$9K Sell
23
-2
-8% -$787 ﹤0.01% 382
2014
Q3 		$9K Buy
25
+2
+9% +$670 ﹤0.01% 360
2014
Q2 		$6K Buy
23
+5
+28% +$1.48K ﹤0.01% 428
2014
Q1 		$5K Buy
18
+2
+13% +$616 ﹤0.01% 456
2013
Q4 		$4K Buy
16
+2
+14% +$575 ﹤0.01% 493
2013
Q3 		$4K Hold
14
– – ﹤0.01% 494
2013
Q2 		$3K Buy
+14
New +$3.26K ﹤0.01% 584

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Alexandria Capital's REGN Position: Q3 2021 in Review

Alexandria Capital increased its Regeneron Pharmaceuticals (REGN) stake by 4.3% in Q3 2021, buying an estimated $292K and bringing the position to 11,505 shares worth $6.96M. The position accounts for 0.64% of the portfolio, ranked #55.

Alexandria Capital first reported a position in REGN in Q2 2013 and has held it in 26 quarters since. 1,018 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Alexandria Capital held 11,505 shares of Regeneron Pharmaceuticals worth $6.96M as of Q3 2021.
  • Alexandria Capital bought 471 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $292K.
  • Regeneron Pharmaceuticals made up 0.64% of Alexandria Capital's portfolio in Q3 2021, its #55 holding.
  • Alexandria Capital first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 26 quarters since.
  • 1,018 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.